Figure S1 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation | Synapse
September 4, 2024
Figure S1 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Figure S1. Preclinical characterization of PF-07799933 and comparison to other RAF inhibitors.